XENE
NASDAQ · Biotechnology
Xenon Pharmaceuticals Inc
$39.75
-17.60 (-30.69%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+6.43%
YTD
-10.65%
Open$44.02
Previous Close$57.35
Day High$44.85
Day Low$39.08
52W High$72.66
52W Low$35.97
Volume—
Avg Volume684.6K
Market Cap5.68B
P/E Ratio—
EPS$-4.74
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$42.54
Below
SMA 200
$37.78
Above
RSI (14)
57.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
26 analysts
Price Target
-49.7% upside
Current
$39.75
$39.75
Target
$19.98
$19.98
$12.55
$19.98 avg
$22.13
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 13.52M | 14.59M | 1.14B |
| Net Income | -623,637,259 | -605,799,819 | -213,860,892 |
| Profit Margin | -4,612.1% | -4,381.5% | -18.8% |
| EBITDA | -668,017,439 | -684,961,216 | -248,558,556 |
| Free Cash Flow | — | — | -268,893,932 |
| Rev Growth | -7.4% | -7.4% | +15.1% |
| Debt/Equity | — | — | 0.33 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $263.96 | -0.02% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $385.65 | +1.55% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $150.11 | -0.52% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $508.34 | -1.55% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $784.85 | -0.58% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $239.56 | -2.42% | 40.0 | 32.33B |